| |
Direct Compressible Excipients
|
Kollidon® VA 64 |
|
Copovidone for use in granulation and as a dry binder in tablets, capsules and granules,
as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent
in topical sprays. |
|
Kollidon® VA 64 Fine |
|
Copovidone especially designed for roller compaction and dry binding in DC formulations. |
|
Kollidon® SR |
|
Kollidon® SR is a blend of 80% polyvinylacetate and 20% povidone in powder form.
This excipient is applied in sustained-release matrix tablets that are manufactured
by direct compression and have pH-independent release characteristics. |
|
Ludiflash® |
| Ludiflash is an excipient for fast disintegrating solid oral dosage forms,
especially oral dispersible tablets (ODT). It is suitable for direct compression manufacturing by simply blending
the excipient with the active and a lubricant. Tabletting and packaging can be accomplished on standard machines
and with standard packaging like push-through blisters or PE-containers: Ludiflash is thus applicable for a very
cost efficient production pathway. Ludiflash tablets show high hardness, low friability and disintegrate within
less than 30 seconds in the mouth with a smooth and pleasant sensation.
|
 |
Dr. Ralf Widmaier would have made it big in ice cream.
After all, he knows how to create products that simply
melt in the mouth.
As the Ludiflash® product manager, he and his team are
committed to creating excipients that dissolve to a soft, creamy consistency. Which makes Ludiflash his pride and joy. Find out more about our product innovation Ludiflash.
|
|
Ludipress® |
|
Pregranulated excipient which combines the functional tablet components filler,
binder and disintegrant. It consists of lactose monohydrate, Kollidon® 30 and Kollidon® CL.
The product is designed for instant release formulations and is suitable for actives in all indication groups. |
|
Ludipress® LCE |
|
For tablets that do not necessarily contain a disintegrant, such as lozenges,
chewables and effervescents, this granulated excipient consists of lactose monohydrate and Kollidon® 30. |
|
|
 |
News |
| |
|
November 5, 2009:
Color-perfect, efficient, environment-friendly tablet
production
(english) October 15, 2009:
Phenylephrine from BASF relieves runny noses,
coughs and sore throats
(english) October 13, 2009:
Soluplus® – for effective drug delivery
(english) October 12, 2009:
BASF showcases expertise at the CPhI worldwide in Madrid
(english) September 25, 2009:
Kollicoat® monograph published in European Pharmacopoeia
(english)
|
|
 |
Product Search |
 |
|
 |
Order Samples |
|
| |
|